Skip to main content
. 2023 Jul 7;14:1198562. doi: 10.3389/fimmu.2023.1198562

Table 6.

Adverse events.

All (n=91)
Symptoms Any grade Grade 3-4
Any adverse event 88 (96.7%) 22 (24.2%)
Fatigue 10 (11.0%) 1 (1.1%)
Hypertension 30 (33.0%) 4 (4.4%)
Decreased appetite 23 (25.3%) 3 (3.3%)
Diarrhea 12 (13.1%) 4 (4.4%)
Hypothyroidism 4 (4.4%) 0
Proteinuria 3 (3.3%) 0
Dysphonia 2 (2.2%) 0
Epistaxis 2 (2.2%) 0
Fever 5 (5.5%) 0
Edema 3 (3.3%) 0
Cramps 3 (3.3%) 0
Nausea 13 (14.3%) 0
Vomiting 6 (6.6%) 0
Pneumonia 1 (1.1%) 0
Abdominal distension 2 (2.2%) 0
Hand-foot skin reaction 3 (3.3%) 0
Increased blood bilirubin 22 (24.2%) 4 (4.4%)
Rash 6 (6.6%) 0
Abdominal pain 2 (2.2%) 0
Increased creatinine 1 (1.1%) 0
ALT elevation 24 (26.4%) 0
AST elevation 47 (51.6%) 6 (6.6%)

ALT, alanine transaminase; AST, aspartate aminotransferase.